Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC

Liquid biopsy has emerged as a minimally invasive alternative to tumor tissue analysis for the management of lung cancer patients, especially for epidermal growth factor receptor (EGFR) oncogene addicted tumor. In these patients, despite the clear benefits of tyrosine kinase inhibitors therapy, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacovino, Marialucia, Ciaramella, Vincenza, Paragliola, Fernando, Suarato, Gabriella, Busiello, Gesualdina, Sparano, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400718/
https://www.ncbi.nlm.nih.gov/pubmed/36046387
http://dx.doi.org/10.37349/etat.2020.00024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400718/
https://www.ncbi.nlm.nih.gov/pubmed/36046387
http://dx.doi.org/10.37349/etat.2020.00024

Ejemplares similares